Building a Better Stop-Gap: Vascular Access for Dialysis

Ask any group of nephrologists what the biggest problem is in hemodialysis today and most likely they'll say vascular access. Vasca Inc. believes this is just the sort of problem that technology can address. The young company hopes to convince a fragmented group of physicians that its subcutaneous valve that bridges patients to the optimal, but less used, permanent type of access option, the arteriovenous fistula, will provide clinical and costs benefits across the continuum of dialysis therapy.